title: Editorial: Combining Forces to Improve Alzheimer's Disease Drug Discovery: The Symptomatic Battle.
authors.forename: Julie
authors.initials: J
authors.lastname: Deguil
authors.forename: Alexandra
authors.initials: A
authors.lastname: Auffret
authors.forename: Esther
authors.initials: E
authors.lastname: Schenker
authors.forename: Fabienne
authors.initials: F
authors.lastname: Aujard
authors.forename: Yves
authors.initials: Y
authors.lastname: Lamberty
authors.forename: David
authors.initials: D
authors.lastname: Bartrès-Faz
authors.forename: Olivier
authors.initials: O
authors.lastname: Blin
authors.forename: Joëlle
authors.initials: J
authors.lastname: Micallef
authors.forename: Jill C
authors.initials: JC
authors.lastname: Richardson
authors.affiliation: Department of Pharmacology, University Lille Nord de France, Lille, France. regis.bordet@univ-lille2.fr.
authors.forename: Régis
authors.initials: R
authors.lastname: Bordet
mesh_terms: D000046:Academic Medical Centers; D000544:Alzheimer Disease / Q000188:drug therapy* / Q000503:physiopathology*; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D055808:Drug Discovery; D004345:Drug Industry; D006801:Humans; D007373:Interinstitutional Relations
chemical_list: D014150:Antipsychotic Agents